Stereotactic radiosurgery (SRS) is a precise form of radiation therapy used to treat tumors. New technologies are continuously emerging to improve treatment planning and delivery. This review explores the potential of ChatGPT, a large language model (LLM), as a transformative tool in SRS. We discuss how ChatGPT could be used for tasks like treatment planning optimization, streamlining workflows, and even patient education. While acknowledging the limitations of current research and the need for rigorous validation, we highlight the potential of LLMs to enhance the efficiency and effectiveness of SRS.
Stereotactic radiosurgery (SRS) delivers high doses of radiation therapy with pinpoint accuracy to treat tumors in the brain, spine, lungs, and other body parts. Optimizing treatment plans is crucial for maximizing tumor control while minimizing side effects. Artificial intelligence (AI) is making inroads into healthcare, and large language models (LLMs) like ChatGPT present exciting possibilities for SRS.
SRS treatment planning is a complex process involving various steps. ChatGPT could potentially:
Analyze Patient Data: ChatGPT can analyze vast amounts of patient data, including scans and medical history, to identify optimal treatment targets and potential risk factors.
Optimize Treatment Parameters: LLMs can analyze historical data and clinical trials to recommend optimal radiation doses, fractionation schemes, and beam geometry for individual patients.
Identify Potential Complications: By analyzing vast datasets, ChatGPT could help predict and mitigate potential side effects like radiation-induced toxicity.
Beyond treatment planning, ChatGPT could transform SRS workflows by:
Automating Repetitive Tasks: Generating reports, summarizing complex data, and scheduling follow-up appointments are tasks ChatGPT could automate, freeing up valuable time for clinicians.
Personalized Patient Education: ChatGPT can generate clear and concise educational materials tailored to individual patient needs and literacy levels.
Research Collaboration: LLMs can analyze vast amounts of medical literature, summarizing findings and facilitating research collaboration in SRS.
Despite its promise, ChatGPT's application in SRS requires careful consideration:
Limited Clinical Data: LLMs require extensive training data for reliable outputs. Currently, limited clinical data in SRS might restrict its effectiveness.
Black Box Problem: The inner workings of LLMs are often opaque, making it difficult to understand how they arrive at their outputs. Transparency and explainability are crucial for trust in clinical decision-making.
Ethical Considerations: Data privacy, potential biases within the training data, and ensuring responsible use of AI in patient care are all ethical considerations.
ChatGPT represents a novel tool with the potential to revolutionize SRS. Further research is needed to validate its effectiveness and integrate it responsibly into clinical workflows. By addressing the challenges and fostering collaboration between AI developers and healthcare professionals, we can unlock the true potential of LLMs for improved patient outcomes in SRS.
1.
Retired Olympic athletes at greater risk of skin cancer and osteoarthritis, research reveals
2.
Three Cycles of Chemo Noninferior to Six for Rare Childhood Eye Cancer
3.
Celebrity Cancers Stoking Fear? Cisplatin Shortage Ends; Setback for Anti-TIGIT
4.
Year in Review: Non-Small Cell Lung Cancer
5.
Electronic Sepsis Alerts; Reducing Plaques in Coronary Arteries
1.
What Is Carboxyhemoglobin And How Can It Affect Your Health?
2.
Introducing the Corrected Calcium Calculator: A Revolutionary Tool in Medical Assessment
3.
Integrating Immunotherapy and Staging Guidelines in Lung Cancer Treatment
4.
The Technological Revolution in Precision Oncology and Tumor Microenvironment Therapy
5.
The Importance of Having a Quick and Effective Heparin Antidote
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
2.
Navigating the Complexities of Ph Negative ALL - Part XVI
3.
Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World
4.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
5.
Efficient Management of First line ALK-rearranged NSCLC - Part VII
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation